Author: Michael Dionne, DNP, PMHNP-BC | Reforge Psychiatry
Updated: April 5, 2026 Reading Time: 8 min
Table of Contents
TL;DR
- PTSD medication for veterans — specifically SSRIs like Sertraline — shows only 40-60% response rates in combat populations
- Standard protocols were built on civilian trauma research, not military or occupational trauma.
- PTSD involves more than serotonin dysregulation — it involves the HPA axis, glutamate pathways, and the deep nervous system dysregulation
- Glutamate-pathway treatments like ketamine show significant promise for treatment-resistant PTSD.
- IFS and polyvagal-informed approaches address what medication alone can’t reach
- Treatment failure isn’t a ceiling — it’s a data point indicating which mechanism wasn’t targeted.
You went to the VA. Or maybe a civilian provider through TRICARE. You got prescribed Sertraline — maybe Prazosin for the nightmares. They told you to try therapy. Maybe you did. Maybe you didn’t.
A year later, you’re sleeping a little better. You’re not drinking as much. You’re “functional.” But you know what functional looks like from the inside: white-knuckling through Tuesday and managing, not recovering.
Here’s the part nobody said out loud about PTSD medication for veterans: you didn’t fail treatment. Treatment failed you. And there’s data behind that — not just a feeling.
Why PTSD Medication Fails Veterans: The Standard Protocol
The VA’s first-line treatment for PTSD is SSRIs — Sertraline (Zoloft) and paroxetine (Paxil). That hasn’t changed much in 20 years.
The evidence behind that recommendation was largely built on civilian trauma populations. Sexual assault survivors. Accident victims. People whose nervous systems have experienced a single catastrophic event.
Combat trauma is different. Occupational trauma — the kind that accumulates over years of high-stakes work — is different. The exposure isn’t a single event. It’s chronic, repeated, and often morally complex. The brain doesn’t process it the same way.
So when you apply a protocol built on one kind of trauma to a completely different kind, you get what most veterans report: partial response. Symptom management. Not resolution.
Studies on Sertraline in combat PTSD specifically show response rates around 40-60%. “Response” in clinical terms means meaningful symptom reduction — not remission, not recovery. Full remission rates in this population are significantly lower. Most veterans who respond still meet the criteria for PTSD after treatment.
That’s the protocol working as designed. The design is the problem.
Why SSRIs Became the Default
SSRIs target serotonin — a neurotransmitter involved in mood regulation. For depression and anxiety with civilian trauma roots, the evidence is decent.
PTSD in combat and first responder populations involves more than serotonin dysregulation. It involves the HPA axis (your body’s stress hormone system), glutamate pathways (how your brain processes and stores threat signals), and deep nervous system dysregulation that doesn’t respond to serotonin modulation alone.
SSRIs became first-line because they had the most data when the guidelines were written. The guidelines calcified. The science kept moving.
What the Research Actually Shows Now
The most significant shift in PTSD treatment over the last decade isn’t a new medication. It’s a better understanding of the mechanism.
PTSD isn’t just a psychological response to a bad event. It’s a neurobiological state — one in which the brain’s threat-detection system gets stuck in a high-alert pattern that resists verbal therapy and partial serotonin support.
Glutamate-pathway treatments — medications and interventions that target glutamate (the brain’s main excitatory neurotransmitter, responsible for how stress signals are stored and reset) — have shown significant promise in treatment-resistant PTSD. This is where ketamine fits.
Ketamine works on NMDA receptors — part of the glutamate system. Multiple clinical trials have shown a rapid reduction in PTSD symptoms, including intrusive memories and hypervigilance, in patients who didn’t respond to SSRIs. A 2021 study published in Neuropsychopharmacology showed significant PTSD symptom reduction after ketamine infusion, with effects that persisted beyond the acute treatment window. Esketamine (Spravato), the FDA-approved nasal spray form, has shown similar results in treatment-resistant depression with trauma histories.
This isn’t experimental fringe treatment. It’s FDA-approved pharmacology targeting a mechanism that SSRIs don’t reach.
IFS and Polyvagal Approaches — What They Are in Plain English
Internal Family Systems (IFS) is a therapy model based on the idea that trauma creates fragmented parts of the self that operate in conflict — protective parts that drive avoidance, numbing, or hypervigilance; and wounded parts that carry the original pain. The clinical outcome data are early but solid. IFS was added to SAMHSA’s National Registry of Evidence-Based Programs in 2015.
In plain terms, it’s not talk therapy where you describe what happened. It’s structured work that addresses why parts of your nervous system are still running threat protocols from 2007.
Polyvagal theory, developed by researcher Stephen Porges, maps how the autonomic nervous system (the part of your nervous system you can’t consciously control) shifts between states of safety, mobilization, and shutdown. Most veterans with chronic PTSD are stuck in mobilization or shutdown — physiologically, not just psychologically.
Polyvagal-informed treatment focuses on nervous system regulation — teaching the body to access a state of safety before trying to process trauma. It’s not meditation. It’s a targeted intervention based on how the autonomic nervous system actually works.
Neither of these approaches replaces medication where medication is indicated. They address what medication alone can’t reach.
Non-Pharmaceutical Support — Brief and Honest
A few supplements have real evidence behind them — not wellness hype, actual RCT data.
NAC (N-Acetyl Cysteine) modulates glutamate — the same pathway ketamine targets — and has shown reduction in intrusive symptoms and hyperarousal in small but well-designed trials. It’s not a replacement for treatment. It’s a clinically reasonable adjunct.
High-EPA omega-3s have the strongest evidence base of any supplement for depression and neuroinflammation. Most veterans are deficient. The mechanism is real.
These aren’t suggestions from a health food store. They’re evidence-based decisions made with the same rigor as a prescription.
Key Takeaways
- SSRIs show only 40-60% response rates in combat PTSD, and “response” doesn’t mean remission.
- Combat and occupational trauma run on different mechanisms than civilian trauma
- PTSD involves the HPA axis and glutamate pathways, not just serotonin
- Ketamine and other glutamate-targeting treatments show promise for treatment-resistant cases
- IFS and polyvagal approaches address nervous system dysregulation that medication misses
- Treatment failure is diagnostic information — not a verdict
Frequently Asked Questions
Why don’t SSRIs work well for combat PTSD?
SSRIs target serotonin, but combat PTSD involves more than serotonin dysregulation. It engages the HPA axis (stress hormones), glutamate pathways (threat signal processing), and deep autonomic nervous system dysregulation that doesn’t respond to serotonin modulation alone. The protocols were also built primarily on civilian trauma research, not military or occupational trauma.
What is glutamate, and why does it matter for PTSD?
Glutamate is your brain’s main excitatory neurotransmitter — it controls how stress signals are stored and reset. In PTSD, the glutamate system gets stuck in overdrive. Treatments targeting glutamate pathways, such as ketamine, can help reset this system in ways that SSRIs cannot.
Is ketamine FDA-approved for PTSD?
Esketamine (Spravato) is FDA-approved for treatment-resistant depression, and multiple clinical trials show significant PTSD symptom reduction with ketamine infusions. It’s not an experimental fringe treatment — it targets a mechanism SSRIs don’t reach.
What are IFS and polyvagal therapy?
Internal Family Systems (IFS) is a therapy model that addresses fragmented parts of the self created by trauma. Polyvagal-informed treatment focuses on nervous system regulation — teaching the body to access safety before processing trauma. Neither replaces medication where indicated; they address what medication alone can’t reach.
If PTSD medication didn’t work for me, does that mean I’m untreatable?
No. Treatment failure is a data point, not a ceiling. It tells you which mechanism wasn’t targeted. A veteran who didn’t respond to SSRIs isn’t a hard case — they’re a candidate for a different approach targeting different pathways.
If Treatment Didn’t Work — That’s Information
Treatment failure isn’t a ceiling. It’s a data point.
It tells you which mechanism wasn’t targeted. It tells you what pathway to investigate next. A veteran who didn’t respond to SSRIs isn’t a hard case — they’re a candidate for a different approach.
Science has moved significantly in the last decade. Most veterans haven’t been told that yet. That gap is the whole problem.
Suppose your treatment history looks more like “managed” than “better” — that’s worth a conversation. A free 15-minute consult costs nothing and takes less time than a visit to a VA waiting room.
Michael Dionne, DNP, PMHNP-BC, is the founder of Reforge Psychiatry. He is a board-certified psychiatric mental health nurse practitioner and U.S. Army veteran specializing in PTSD treatment, medication management, and telehealth psychiatry for veterans and first responders. Licensed in California, New Hampshire, New York, and Idaho.
References
- Friedman, M. J., et al. (2007). Randomized, double-blind comparison of Sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. Journal of Clinical Psychiatry, 68(5), 711-720.
- Feder, A., et al. (2021). A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. Neuropsychopharmacology, 46(8), 1401-1410.
- Schwartz, R. C. (2021). No Bad Parts: Healing Trauma and Restoring Wholeness with the Internal Family Systems Model. Sounds True.
- Porges, S. W. (2011). The Polyvagal Theory: Neurophysiological Foundations of Emotions, Attachment, Communication, and Self-regulation. W. W. Norton & Company.
- VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder. (2023). Department of Veterans Affairs.